Dr Chan is among the top 2% scientists in the world in their respective fields in a single year since 2021. His main area of research interest is MASLD. As part of his PhD dissertation, he described the two-step approach in non-invasive assessment of liver fibrosis in NAFLD, which has now become the foundation for a simple assessment and referral pathway for the disease in national and international guidelines. He is the lead author for the MSGH Consensus Statements on MAFLD and the contributor for the section on NAFLD in the 6th Edition of the Clinical Practice Guidelines on the Management of Type 2 Diabetes Mellitus for Malaysia. He is also a co-author for the APASL Clinical Practice Guidelines for the Diagnosis and Management of MAFLD. He is actively involved in NASH clinical trials and is in the Global Expert Panel for the ESSENCE study.